StockData
Medicure Inc logo

Medicure Inc (MCUJF) stock

MCUJFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 24, 2026Score 6/30
$3.10+0.12 (+4.07%)

Close on Oct 19, 2026

Medicure r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was C$3.18M, up 3.2% from the year before. Over ten years it grew -4.2% a year on average. The highest annual figure on record is C$6.68M in fiscal 2018.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025C$3.18M+3.2%
FY2024Dec 31, 2024C$3.08M+28.1%
FY2023Dec 31, 2023C$2.41M-12.6%
FY2022Dec 31, 2022C$2.75M+53.3%
FY2021Dec 31, 2021C$1.80M-45.6%
FY2020Dec 31, 2020C$3.30M-24.1%
FY2019Dec 31, 2019C$4.35M-34.9%
FY2018Dec 31, 2018C$6.68M+29.8%
FY2017Dec 31, 2017C$5.15M+41.8%
FY2016Dec 31, 2016C$3.63M-25.4%
FY2015Dec 31, 2015C$4.87M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2025Mar 31, 2025C$570.00K–
Q1 FY2024Mar 31, 2024C$676.00K–

More Medicure figures

See a number that looks wrong?